S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
Log in
NYSE:NHI

National Health Investors Stock Forecast, Price & News

$66.50
+0.39 (+0.59 %)
(As of 12/4/2020 12:00 AM ET)
Add
Compare
Today's Range
$66.13
Now: $66.50
$67.34
50-Day Range
$54.60
MA: $61.26
$66.84
52-Week Range
$31.37
Now: $66.50
$91.12
Volume240,732 shs
Average Volume345,632 shs
Market Capitalization$2.97 billion
P/E Ratio15.61
Dividend Yield6.67%
Beta0.79
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
National Health Investors logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.9Community Rank: 2.1Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.86 out of 5 stars


Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustrySpecialized REITs
SectorFinance
CUSIP63633D10
Phone615-890-9100
Employees17

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$318.08 million
Cash Flow$5.55 per share
Book Value$33.63 per share

Profitability

Net Income$160.46 million

Miscellaneous

Market Cap$2.97 billion
Next Earnings Date2/17/2021 (Estimated)
OptionableOptionable
$66.50
+0.39 (+0.59 %)
(As of 12/4/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NHI News and Ratings via Email

Sign-up to receive the latest news and ratings for NHI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











National Health Investors (NYSE:NHI) Frequently Asked Questions

How has National Health Investors' stock been impacted by COVID-19 (Coronavirus)?

National Health Investors' stock was trading at $70.86 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NHI stock has decreased by 6.2% and is now trading at $66.50.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of National Health Investors?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last year. There are currently 1 sell rating and 7 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for National Health Investors
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than National Health Investors?

Wall Street analysts have given National Health Investors a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but National Health Investors wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is National Health Investors' next earnings date?

National Health Investors is scheduled to release its next quarterly earnings announcement on Wednesday, February 17th 2021.
View our earnings forecast for National Health Investors
.

How were National Health Investors' earnings last quarter?

National Health Investors, Inc. (NYSE:NHI) released its earnings results on Monday, November, 9th. The real estate investment trust reported $0.95 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $1.43 by $0.48. The real estate investment trust earned $84.30 million during the quarter, compared to analyst estimates of $82.87 million. National Health Investors had a return on equity of 12.64% and a net margin of 56.94%. The business's quarterly revenue was up 3.2% compared to the same quarter last year. During the same period last year, the company posted $1.42 earnings per share.
View National Health Investors' earnings history
.

How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors?

National Health Investors announced a quarterly dividend on Tuesday, September 15th. Shareholders of record on Wednesday, September 30th will be given a dividend of $1.102 per share on Friday, November 6th. This represents a $4.41 dividend on an annualized basis and a dividend yield of 6.63%. The ex-dividend date of this dividend is Tuesday, September 29th.
View National Health Investors' dividend history
.

What price target have analysts set for NHI?

8 analysts have issued 12-month price objectives for National Health Investors' stock. Their forecasts range from $40.00 to $94.00. On average, they expect National Health Investors' share price to reach $66.29 in the next year. This suggests that the stock has a possible downside of 0.3%.
View analysts' price targets for National Health Investors
.

Are investors shorting National Health Investors?

National Health Investors saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 879,700 shares, an increase of 35.3% from the October 31st total of 650,300 shares. Based on an average trading volume of 309,300 shares, the days-to-cover ratio is presently 2.8 days. Approximately 2.1% of the company's shares are sold short.
View National Health Investors' Short Interest
.

Who are some of National Health Investors' key competitors?

What other stocks do shareholders of National Health Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

Who are National Health Investors' key executives?

National Health Investors' management team includes the following people:
  • Mr. D. Eric Mendelsohn, Pres & CEO (Age 58, Pay $1.03M)
  • Mr. John L. Spaid, Exec. VP of Fin. & CFO (Age 60, Pay $417.61k)
  • Mr. Kevin Carlton Pascoe, Chief Investment Officer (Age 39, Pay $569.55k)
  • Ms. Kristin Sallee Gaines, Chief Credit Officer (Age 48, Pay $503.65k)
  • Mr. David Louis Travis, Sr. VP & Chief Accounting Officer (Age 45)
  • Mr. Dana Rolfson Hambly CFA, Director of Investor Relations
  • Mr. Kimberly Ouimet, Director of Corp. Compliance & HR
  • Ms. Michelle R. Kelly, Sr. VP of Investments
  • Susan V. Sidwell, Corp. Sec.
  • Ms. Colleen Schaller, Real Estate Transaction Mang.

What is National Health Investors' stock symbol?

National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."

Who are National Health Investors' major shareholders?

National Health Investors' stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.43%), State Street Corp (4.13%), Hamlin Capital Management LLC (2.08%), Charles Schwab Investment Management Inc. (1.16%), Principal Financial Group Inc. (1.03%) and GW&K Investment Management LLC (0.94%). Company insiders that own National Health Investors stock include D Eric Mendelsohn, James R Jobe, Kevin Carlton Pascoe, Kristin Sallee Gaines, Robert A Mccabe, Jr, Robert G Adams, Robert T Webb and W Andrew Adams.
View institutional ownership trends for National Health Investors
.

Which major investors are selling National Health Investors stock?

NHI stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Carlson Capital L P, State Street Corp, LSV Asset Management, BlackRock Inc., Principal Financial Group Inc., UBS Oconnor LLC, and Truist Financial Corp. Company insiders that have sold National Health Investors company stock in the last year include D Eric Mendelsohn, and Kevin Carlton Pascoe.
View insider buying and selling activity for National Health Investors
.

Which major investors are buying National Health Investors stock?

NHI stock was bought by a variety of institutional investors in the last quarter, including Charles Schwab Investment Management Inc., Hamlin Capital Management LLC, Arrowstreet Capital Limited Partnership, UBS Asset Management Americas Inc., NN Investment Partners Holdings N.V., Great West Life Assurance Co. Can, Jennison Associates LLC, and Paloma Partners Management Co. Company insiders that have bought National Health Investors stock in the last two years include Robert G Adams, Robert T Webb, and W Andrew Adams.
View insider buying and selling activity for National Health Investors
.

How do I buy shares of National Health Investors?

Shares of NHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is National Health Investors' stock price today?

One share of NHI stock can currently be purchased for approximately $66.50.

How big of a company is National Health Investors?

National Health Investors has a market capitalization of $2.97 billion and generates $318.08 million in revenue each year. The real estate investment trust earns $160.46 million in net income (profit) each year or $5.50 on an earnings per share basis. National Health Investors employs 17 workers across the globe.

What is National Health Investors' official website?

The official website for National Health Investors is www.nhireit.com.

How can I contact National Health Investors?

National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust can be reached via phone at 615-890-9100 or via email at [email protected]

This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.